Isolated paraneoplastic optic neuropathy associated with small-cell lung cancer and anti-CV2 antibodies [8]

Journal of Neurology

Volumn 254, Issue 8, 2007, Pages 1131-1132

  Arés Luque, Adrián ^a   Garcia Tunon L A ^a   Saiz, A ^b   Cabezas, B C ^a   Hernandez Echebarria L E ^a   Franco, M ^a   Toribio, A ^a   Tejada, J ^a   Graus, F ^b  

^a HOSPITAL DE LEÓN   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CISPLATIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 5 IMMUNOGLOBULIN G ANTIBODY; ETOPOSIDE; IMMUNOGLOBULIN G ANTIBODY; METHYLPREDNISOLONE; STEROID; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; BLOOD ANALYSIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; ELECTRORETINOGRAPHY; EVOKED VISUAL RESPONSE; EYE MOVEMENT; FLUORESCENCE ANGIOGRAPHY; HUMAN; LETTER; LUNG BIOPSY; LUNG SMALL CELL CANCER; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; THORACOSCOPY; VISUAL ACUITY;

AUTOANTIBODIES; CARCINOMA, SMALL CELL; HUMANS; MALE; MIDDLE AGED; OPTIC NERVE DISEASES; PARANEOPLASTIC SYNDROMES;

EID: 34548431737     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-0471-x     Document Type: Letter

References (14)

1. Dalmau JO, Posner JB (1997) Paraneoplastic syndromes affecting the nervous system. Semin Oncol 24:318-328
2. Asproudis IC, Nikas AN, Psilas KG (2005) Paraneoplastic optic neuropathy in a patient with a non-small cell lung carcinoma: a case report. Eur J Ophthalmol 15:420-423
3. Bernal F, Shamsili S, Rojas I, Sanchez-Valle R, Saiz A, Dalmau J, Honnorat J, Sillevis Smitt P, Graus F (2003) Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease. Neurology 60:230-234
4. Cross SA, Salomao DR, Parisi JE, Kryzer TJ, Bradley EA, Mines JA, Lam BL, Lennon VA (2003) Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Ann Neurol 54:38-50
5. Hoh ST, Teh M, Chew SJ (1991) Paraneoplastic optic neuropathy in nasopharyngeal carcinoma-report of a case. Singapore Med J 32:170-173
6. Ing EB, Augsburger JJ, Eagle RC (1996) Lung cancer with visual loss. Surv Ophthalmol 40:505-510
7. Mason WP, Graus F, Lang B, Honnorat J, Delattre JY, Valldeoriola F, Antoine JC, Rosenblum MK, Rosenfeld MR, Newsom-Davis J, Posner JB, Dalmau J (1997) Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain 120:1279-1300
8. Peterson K, Rosenblum MK, Kotanides H, Posner JB (1992) Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 42:1931-1937
9. Honnorat J, Antoine JC, Derrington E, Aguera M, Belin MF (1996) Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 61:270-278
10. Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA (2001) CRMP-5 neuronal autoantibody: marker of lung cancer and thymomarelated autoimmunity. Ann Neurol 49:146-154
11. Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler Ch, Verschuuren JJ, Vincent A, Voltz R (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135-1140
12. Bataller L, Dalmau JO (2004) Paraneoplastic disorders of the central nervous system: update on diagnostic criteria and treatment. Semin Neurol 24:461-471
13. de la Sayette V, Bertran F, Honnorat J, Schaeffer S, Iglesias S, Defer G (1998) Paraneoplastic cerebellar syndrome and optic neuritis with anti-CV2 antibodies: clinical response to excision of the primary tumour. Arch Neurol 55:405-408
14. Lladó A, Mannucci P, Carpentier AF, Paris S, Blanco Y, Saiz A, Delattre JY, Graus F (2004) Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes. Neurology 63:1947-1949